| Edward Earl Rotan Jr, MD | |
|
715 N Fielder Rd, Arlington, TX 76012-4695 | |
| (817) 261-1626 | |
| (817) 275-0441 |
| Full Name | Edward Earl Rotan Jr |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 21 Years |
| Location | 715 N Fielder Rd, Arlington, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780734582 | NPI | - | NPPES |
| 00A919461 | Other | CA | INDIVIDUAL PTAN NO. CA. |
| P00375737 | Other | CA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | A91946 (California) | Primary |
| 207Q00000X | Family Medicine | A91946 (California) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Primary Health Physicians Pllc | 7810237740 | 146 |
News Archive
Researchers from North Carolina State University have found that a commonly used drug made from secondary bile acids can affect the life cycle of Clostridioides difficile (C. diff) in vitro and reduce the inflammatory response to C. diff in mice.
CSL Behring announced today that Helixate® FS, Antihemophilic Factor (Recombinant), has been approved by the U.S. Food and Drug Administration (FDA) for routine prophylaxis in children with hemophilia A who are 16 years old or younger and do not have pre-existing joint damage.
The functional differences between autistic and non-autistic brains have been isolated for the first time, following the development of a new methodology for analysing MRI scans.
Repairing birth defects in the womb. Inserting a tiny laser into the mother's uterus to seal off an abnormal blood flow and save fetal twins. Advancing the science that may allow doctors to deliver cells or DNA to treat sickle cell anemia and other genetic diseases before birth.
› Verified 5 days ago
| Entity Name | Primary Health Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770048704 PECOS PAC ID: 7810237740 Enrollment ID: O20190312003418 |
News Archive
Researchers from North Carolina State University have found that a commonly used drug made from secondary bile acids can affect the life cycle of Clostridioides difficile (C. diff) in vitro and reduce the inflammatory response to C. diff in mice.
CSL Behring announced today that Helixate® FS, Antihemophilic Factor (Recombinant), has been approved by the U.S. Food and Drug Administration (FDA) for routine prophylaxis in children with hemophilia A who are 16 years old or younger and do not have pre-existing joint damage.
The functional differences between autistic and non-autistic brains have been isolated for the first time, following the development of a new methodology for analysing MRI scans.
Repairing birth defects in the womb. Inserting a tiny laser into the mother's uterus to seal off an abnormal blood flow and save fetal twins. Advancing the science that may allow doctors to deliver cells or DNA to treat sickle cell anemia and other genetic diseases before birth.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Edward Earl Rotan Jr, MD 19772 Macarthur Blvd, Suite 210, Irvine, CA 92612-2413 Ph: (949) 975-0620 | Edward Earl Rotan Jr, MD 715 N Fielder Rd, Arlington, TX 76012-4695 Ph: (817) 261-1626 |
News Archive
Researchers from North Carolina State University have found that a commonly used drug made from secondary bile acids can affect the life cycle of Clostridioides difficile (C. diff) in vitro and reduce the inflammatory response to C. diff in mice.
CSL Behring announced today that Helixate® FS, Antihemophilic Factor (Recombinant), has been approved by the U.S. Food and Drug Administration (FDA) for routine prophylaxis in children with hemophilia A who are 16 years old or younger and do not have pre-existing joint damage.
The functional differences between autistic and non-autistic brains have been isolated for the first time, following the development of a new methodology for analysing MRI scans.
Repairing birth defects in the womb. Inserting a tiny laser into the mother's uterus to seal off an abnormal blood flow and save fetal twins. Advancing the science that may allow doctors to deliver cells or DNA to treat sickle cell anemia and other genetic diseases before birth.
› Verified 5 days ago
Tri Minh Nguyen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 715 N Fielder Rd, Arlington, TX 76012 Phone: 817-261-1626 | |
Alexander L Berlin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1115 W Randol Mill Rd Ste 200, Arlington, TX 76012 Phone: 817-303-6647 Fax: 817-303-6651 | |
Dr. Todd O Moore, MD, PA Dermatology Medicare: Medicare Enrolled Practice Location: 711 E Lamar Blvd Ste 200, Arlington, TX 76011 Phone: 817-795-7546 Fax: 817-226-7546 | |
Luat Q Nguyen, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3132 Matlock Rd, 307, Arlington, TX 76015 Phone: 817-468-3131 Fax: 817-468-8936 | |
David Randal Hensley, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 300 W Arbrook Blvd, Suite D, Arlington, TX 76014 Phone: 817-701-4777 Fax: 817-701-2323 | |
Victoria W Serralta, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8015 S Cooper St, Arlington, TX 76001 Phone: 817-453-4440 Fax: 817-453-7755 | |
Lily Y. Li, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 811 W I-20, Suite G40, Arlington, TX 76017 Phone: 817-466-8651 Fax: 817-466-2503 |